Rasouli, N., Younes, N., Ghosh, A., Albu, J., Cohen, R. M., DeFronzo, R. A., Diaz, E., Sayyed Kassem, L., Luchsinger, J. A., McGill, J. B., Sivitz, W. I., Tamborlane, W. V., Utzschneider, K. M., Kahn, S. E., Crandall, J. P., McKee, M. D., Behringer-Massera, S., Brown-Friday, J., … Xhori, E. (2024). Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes Care, 47(4), 580–588. https://doi.org/10.2337/dc23-1070
Subjects:
Diabetes Mellitus, Type 2
(MeSH)
Insulin Resistance
(MeSH)
Metformin
(MeSH)
Sulfonylurea Compounds
(MeSH)
Management of Diabetes Mellitus and Cardiovascular Risk
(OpenAlex Topic)
Pancreatic Islet Dysfunction and Regeneration
(OpenAlex Topic)
Role of AMP-Activated Protein Kinase in Cellular Metabolism
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.2337/dc23-1070
PMID:
DOI:
Journal:
Publication Date:
Data Source:
OpenAlex